Antibodies to tumor associated proteins
AssigneeAgensys, Inc.
InventorsArthur B. Raitano, Karen Jane Meyrick Morrison, Wangmao Ge, Pia M. Challita-Eid, Aya Jakobovits
Life of this patent
Estimating the term…
Abstract
A novel gene 024P4C12 (also designated 24P4C12) and its encoded protein, and variants thereof, are described wherein 24P4C12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 24P4C12 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 24P4C12 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 24P4C12 can be used in active or passive immunization.
Claims3
A method to detect, in a peripheral blood sample, cells expressing a protein that comprises the amino acid sequence of SEQ ID NO:7, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17 or SEQ ID NO:19, which method comprises:
- contacting cells in the peripheral blood sample with an antibody or fragment thereof that binds said protein, and
- detecting binding of said antibody or fragment to said cells,
- whereby said binding indicates that the cells express the gene encoding said protein.
Dependencies are inferred from the claim text.